$PG

P&G earnings beat by $0.11, revenue topped estimates

P&G (NYSE: PG) reported Q1 EPS of $2.00, beating estimates by $0.11, with revenue at $23.28B, topping expectations. The company's FY 2027 EPS guidance of $6.89-$7.11 is below the analyst consensus. P&G's stock is up 6.40% over the last 3 months and 3.04% over the last 12 months, with a 'good performance' financial health score according to InvestingPro.

Original reporting
Published Oct 22, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bearish
high confidence
Mentioned
$PG
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PGBearishHigh
01

Why it matters

The earnings beat offsets the guidance miss, creating mixed signals for traders.

02

Market read

Large‑cap earnings with guidance below consensus can move the stock and influence sector sentiment.

03

What to watch

Strong cash flow and a solid balance sheet may cushion the impact of the guidance miss.

Relevance 9/10Novelty 9/10Timing: today after earnings release

Background

P&G's quarterly results are a key indicator for the consumer‑goods sector.

Company-level read

Ticker impact

$PGBearishHigh confidence
Context

P&G reported Q1 EPS of $2.00 beating estimates and gave FY 2027 guidance of $6.89‑$7.11, below consensus.

Expected impact

likely downside as investors price in weaker guidance

Evidence & confidence

The beat is modest and the guidance shortfall is material for a large‑cap consumer staple, prompting short‑term price weakness.

Market effects

Consumer staples may see broader pressure if peers follow P&G's guidance trend.

U.S. markets could open lower on consumer‑staple weakness.

Limited to U.S. equities; minimal global ripple.

Counterpoint

The earnings beat could support a short‑term rally if investors focus on the surprise EPS.

Key entities

  • Procter & Gamble

    Consumer goods conglomerate reporting Q1 results.

Related articles

$PGHighAI 9/10

Procter & Gamble Stocks Gain 5.62% on Volume-Led Quarter

Procter & Gamble (PG) reported a 4% sales increase to $23.3B in Q1, driven by volume growth. Shares rose 5.62% to $165.65. Earnings grew 1% to $1.97 per share, but higher costs impacted margins. Operating cash flow was $5.8B, supporting dividends and buybacks. The stock trades near its GF Value estimate.

$PGMedAI 8/10

P&G (PG) Q1 2027 Earnings Call Transcript

P&G (PG) reported Q1 2027 earnings with organic sales growth across all 10 product categories and 6 regions. North America and Europe grew 3% and 4% respectively, while Greater China saw 8% growth. Core EPS was $2, down 1 point YoY. The company maintained guidance for fiscal 2027 and highlighted successful product launches like Pantene's Abundant and Strong, Pampers Amoira, and Fairy Dish.

$PGMedAI 8/10

The Procter & Gamble Company Q1 2027 Earnings Call Summary

Procter & Gamble reported Q1 2027 organic sales growth of 4.0%, driven by volume increases and strategic interventions. Market share improved in the U.S. and China, with the latter benefiting from competitive dynamics. The company maintained fiscal 2027 guidance for 1%-3% organic sales growth, despite a $1.4 billion after-tax headwind from raw materials and energy. Management expects sequential acceleration in sales growth and plans to offset costs through productivity gains and pricing actions.